Gastric Space-Occupying Devices Market Outlook (2022-2032)

[300+ Pages Report] The global gastric space-occupying devices market was valued at US$ 197.5 Mn in 2021. As per the report, demand in the market will increase at an impressive 13.7% CAGR over the forecast period, with the market size reaching US$ 810.8 Mn by 2032. Gastric balloons are leading the market in terms of product with a market share of around 97.0% in 2021.

Attributes Key Statistics
Gastric Space-Occupying Devices Market Base Year Value (2021) US$ 197.5 million
Estimated Market Size (2022) US$ 224.6 million
Projected Market Valuation (2032) US$ 810.8 million
Value-based CAGR (2022-2032) 13.7%
Market Share of Top 5 Countries 52.0%

Despite advancements in lifestyle interventions, obesity management pharmacotherapies and metabolic or bariatric surgery, the healthcare burden due to obesity continues to increase. Thus, endoscopic bariatric therapies (EBTs) are gaining traction as they are effective, safe, reversible, and economical. These therapies allow treatment of individuals that are unable to undergo bariatric surgery. Among the endoscopic modalities, the employment of a space-occupying device is one of the most ancient and effective therapies.

Considering the large market size of obesity treatment and the small percentage of patients treated with drugs or bariatric surgery, gastric space-occupying devices can play a major role in the management of obesity.

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

2017-2021 Gastric Space-Occupying Devices Market Historic Outlook Vs 2022-2032 Forecast

The market value for gastric space-occupying devices was approximately 5.5% of the overall US$ 3.6 Bn worth weight loss management market in 2021. Sales of gastric space-occupying devices increased at a CAGR of 5.4% between 2017 to 2021, owing to high demand for minimally invasive surgeries for obesity management.

The global prevalence of obesity almost tripled between 1975 and 2020. In 2020, globally over 2 billion adults were overweight (body mass index (BMI) > 25) and more than 600 million were obese (BMI > 30). In Europe, nearly 50% of the population is overweight and more than 30% is obese.

Obesity, along with its obesity-related disorders such as diabetes, hypertension, non-alcoholic fatty liver disease, hyperlipidemia, and obstructive sleep apnea has become a global burden. If the incidence of obesity continues on its current trajectory, nearly half of the adult population will have obesity issues by 2030.

Although widely accessible for managing obesity, traditional therapeutic modalities including lifestyle change and dietary counselling are less effective. Contrarily, patients who have not improved after receiving more conventional medical care but prefer not to undergo surgery can consider anti-obesity medical devices.

Gastric space-occupying devices are positioned to bridge the gap between more conservative treatments and more aggressive interventions such as bariatric surgery. Gastric space-occupying device therapy is more advantageous when compared to bariatric surgery, as they are less invasive in nature, and promote ease of performance, and reversibility.

These devices are available upon prescription or as over-the-counter products. Thus, several advantages of these medical devices are expected to increase the demand for gastric space-occupying devices during the forecast period.

Owing to the rising prevalence of obesity and growing demand for minimally invasive surgical procedures in obesity treatment, demand in the global gastric space-occupying devices market is anticipated to grow at a CAGR of 13.7% during the forecast period.

Gastric Space-Occupying Devices Market

What are the Key Opportunities for the Gastric Space-Occupying Devices Manufacturers?

Endoscopic bariatric therapies can be a sustainable treatment option for obesity management. Along with safety and efficacy of data, these therapies will be the most successful treatment in the next few years. Several researchers are focusing on the tandem and progressive use of a combination of space-occupying endoscopic devices and weight loss drug treatment to enhance the stability of weight loss with a long-lasting effect on obesity and associated diseases.

The global healthcare burden due to obesity accounts for around US$ 2 trillion yearly or around 2.8% of GDP. This is approximately equal to the worldwide effect of smoking or armed violence, war, and terrorism (McKinsey Global Institute, 2014). The tax on obesity in healthcare systems alone is between 2% and 7% of all healthcare expenditures in developed countries. These figures indicate that obesity is considered one of the top 3 community problems.

To manage the obesity-related healthcare burden, governments are taking initiatives to create awareness among people which will create opportunities for key players to be actively involved in the development and launch of cost-effective solutions for obesity management.

Sabyasachi Ghosh
Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Which Factors are Restraining Demand for Gastric Space-Occupying Devices?

The key challenges in the development of gastric space-occupying devices are the lack of specific regulatory guidance and inconsistencies in the time and cost of approval processes in different countries.

Awareness is also an obstacle in the adoption of gastric space-occupying devices. In the realm of weight-loss management, they are still relatively unknown to a large part of the population.

Additionally, increasing product recalls are also hampering growth to an extent. Several gastric space-occupying devices have been withdrawn by manufacturers from the market in the U.S. after approval by the FDA (e.g., ReShape integrated dual balloon system and Garren gastric bubble.

The use of gastric space-occupying devices is a relatively new technology for weight-loss treatment. Lack of reimbursement for such procedures in most countries can potentially hinder growth. Mostly, health insurance plans have fitness criteria of BMI of 35 or 45 for providing reimbursement for obesity management treatments. Though, patients are eligible for gastric space-occupying devices treatment at BMI 27 and are thus not reimbursed.

Furthermore, most countries treat gastric space-occupying devices as a primary procedure which is in the investigational stage. The therapy is not included in the reimbursement policies of Medicaid (CMC) and Medicare in the U.S. with a similar scenario existing in Australia, Canada, and other countries in Asia and Europe.

Country-wise Insights

What is the U.S. Gastric Space-Occupying Devices Market Outlook?

“High Incidence of Obesity Related Disorders in U.S. is Spurring Demand for Gastric Space-Occupying Devices”

The U.S. dominated the North America market in 2021, holding about 83.3% of the market share. As per the report, the trend is expected to continue over the assessment period increasing demand for minimally invasive surgeries for obesity management

In 2017, the American Society for Metabolic and Bariatric Surgery (ASMBS) included gastric space-occupying devices in the list of procedures and devices approved by the society as a treatment option. The sanction and endorsements of this treatment by the ASMBS are expected to increase the adoption of gastric space-occupying devices in the U.S.

What is Driving the U.K. Gastric Space-Occupying Devices Market?

“Rapid Adoption of Anti-Obesity Medica Devices in the U.K. Will Boost Sales”

Demand in the U.K. market is set to increase at a CAGR of 12.5% in the Europe gastric space-occupying devices market during the forecast period.

Non-invasiveness often favoured by both clinicians and patients in the U.K. Similarly, innovation and techniques to challenge obesity are increasing in the country, and several key players are competing by innovating.

High adoption of obesity management treatments, and the availability of skilled professionals are some of the key factors contributing to the growth in the market.

What Makes the China Gastric Space-Occupying Devices Market Attractive?

“Rising Preference for Minimally Invasive Surgeries in China Will Fuel Sales”

Sales in the China market are expected to increase at a 14.4% CAGR over the assessment period.

In the past four years, the rates of obesity in China have rapidly increased, along with economic growth, urbanisation, and globalisation. According to the Chinese Residents Chronic Diseases and Nutrition report, in China over 50% of adults and 20% of school-age children were found to be obese in 2020. This figure indicates the need for obesity management and increased demand for EBT, which is ultimately fueling demand for gastric space-occupying devices.

Furthermore, several government initiatives to create awareness are also supplementing the growth in the market. For instane, The Obesity Prevention and Control Society of Chinese Nutrition Society (OPCS-CNS) has collaborated with other government bodies to carry out a series of activities to inspire individuals to pay attention to the obesity problem and take more practical actions.

Get the data you need at a Fraction of the cost

Personalize your report by choosing insights you need
and save 40%!

Category-wise Insights

Which is the Most Popular Product in the Gastric Space-Occupying Devices Market?

“Demand for Gastric Balloons Will Gain Momentum”

Based on product type, sales of gastric balloons held the highest market share of about 97.0% in the market in 2021 and are expected to grow at a CAGR of 13.67% over the forecast period. Through endoscopy, gastric balloons are inserted into the body and offer weight loss of up to 7 to 8 pounds.

An average 7-pound weight loss is possible with the Orbera gastric balloon. The Obalon gastric balloon, on the other hand, offers an average of 7.4 pounds, or 3.42 percent of their total body weight.

Who is the Leading End User of Gastric Space-Occupying Devices Globally?

“Adoption of Obesity Management Pharmacotherapies in Hospitals Will Remain High”

Hospitals held the highest share of 59.0% in 2021. Rising prevalence of obesity, along with growing healthcare investments across the globe, and government policies for the execution of superior patient care are driving sales in this segment.

Similarly, new clinical trials conducted in multi-speciality hospitals will provide opportunities to the patients to explore new experimental therapies, thus boosting demand.

Competitive Landscape

The gastric space-occupying devices market is fairly consolidated and led by few market players. These players are focusing on product development and expansion strategies to gain traction in the market. For instance:

  • In July 2020, Allurion Technologies expanded business in Asia with the launch of the Elipse Program in Malaysia, Hong Kong, and Singapore. Along with its achievement in Europe, the Middle East, and Latin America, the company’s entry into the Asian region will influence the lives of more than 1 billion people who are overweight or obese in a region that previously had limited access to minimally invasive treatments for obesity management.

Report Scope

Attribute Details
Estimated Market Size (2022) US$ 224.6 million
Projected Market Valuation (2032) US$ 810.8 million
Value-based CAGR (2022 to 2032) 13.7%
Forecast Period 2017 to 2021
Historical Data Available for 2022 to 2032
Market Analysis US$ million for Value
Key Regions Covered North America; Latin America; Europe; South Asia; East Asia; Oceania; and Middle East & Africa
Key Countries Covered The USA, Canada, Brazil, Mexico, Argentina, the UK, Germany, Italy, Russia, Spain, France, BENELUX, India, Thailand, Indonesia, Malaysia, Japan, China, South Korea, Australia, New Zealand, Turkey, GCC, North Africa, and South Africa
Key Market Segments Covered Product, End User, and Region
Key Companies Profiled Apollo Endosurgery, Inc.; Obalon Therapeutics, Inc.; Allurion Technologies, Inc.; Helioscopie; Endalis; MEDSIL; ReShape Medical, Inc.; Lexel Medical; Scientific Intake

Key Market Segments Covered In Gastric Space-Occupying Devices Industry Research

By Product:

  • Gastric Balloons
  • Oral Palatal Space Occupying Devices

By End-User:

  • Hospitals
  • Speciality Clinics
  • Ambulatory Surgical Centers

By Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • The Middle East and Africa (MEA)

Frequently Asked Questions

How much is the gastric space-occupying devices market worth in 2021?

The global gastric space-occupying devices market is worth US$ 197.5 Mn in 2021 and is set to expand 3.6X over the next ten years.

What is the sales forecast for the gastric space-occupying devices market through 2032?

The gastric space-occupying devices market is expected to reach US$ 810.8 Mn by the end of 2032, with sales revenue expected to register a 13.7% CAGR.

What are the key trends shaping the gastric space-occupying devices industry?

The rising prevalence of obesity, growing preference for minimally invasive therapies, and the increasing need for gastric space-occupying devices in obesity management are some of the key trends in this market.

Which are the top 5 countries driving demand for gastric space-occupying devices?

U.S., U.K., Germany, China, and Japan are expected to drive demand for the gastric space-occupying devices industry.

What is the North American market outlook for gastric space-occupying devices?

North America is one of the key markets for gastric space-occupying devices, with the U.S. accounting for about 83.3% of the North American gastric space-occupying devices market in the year 2021.

At what percentage is the demand for gastric space-occupying devices expected to register growth in Europe?

Demand for gastric space-occupying devices in Europe is expected to register a growth of 12.99% over the next ten years.

Which countries are the key producers of gastric space-occupying devices?

The U.S., U.K., and China are the key producers of gastric space-occupying devices.

Who are the key players in the gastric space-occupying devices market sphere?

Apollo Endosurgery, Inc., Obalon Therapeutics, Inc., Allurion Technologies, Inc., Helioscopie, Endalis, MEDSIL, ReShape Medical, Inc., Lexel Medical, and Scientific Intake, is some of the key players in the gastric space-occupying devices industry.

Table of Content
1. Executive Summary
    1.1. Global Market Outlook
    1.2. Demand Side Trends
    1.3. Supply Side Trends
    1.4. Analysis and Recommendations
2. Market Overview
    2.1. Market Coverage / Taxonomy
    2.2. Market Definition / Scope / Limitations
    2.3. Inclusions & Exclusions
3. Key Market Trends
    3.1. Key Trends Impacting the Market
    3.2. Innovation / Development Trends
4. Key Success Factors
    4.1. Key Promotional Strategies, By Key Player
    4.2. Product Adoption/Usage Analysis
    4.3. Technology Assessment
    4.4. Regulatory Scenario
    4.5. Value Chain Analysis
    4.6. Porter’s Analysis
    4.7. PESTEL analysis
5. Market Background
    5.1. Macro-Economic Factors
        5.1.1. Global GDP Growth Outlook
        5.1.2. Global Healthcare Market Outlook
        5.1.3. Per Capita Healthcare Spending Outlook
    5.2. Forecast Factors - Relevance & Impact
        5.2.1. Top Companies Historical Growth
        5.2.2. Product Adoption Rate and Demand
        5.2.3. New Product Launches
        5.2.4. Increase in Demand for Non-invasive Surgeries
        5.2.5. Changing Regulatory Dynamics
    5.3. Market Dynamics
        5.3.1. Drivers
        5.3.2. Restraints
        5.3.3. Opportunity Analysis
6. COVID-19 Crisis Analysis
    6.1. COVID-19 and Impact Analysis
    6.2. 2021 Market Scenario
7. Global Gastric Space-Occupying Devices Market Demand (in Value or Size in US$ Mn) Analysis 2017–2021 and Forecast, 2022–2032
    7.1. Historical Market Value (US$ Mn) Analysis, 2017–2021
    7.2. Current and Future Market Value (US$ Mn) Projections, 2022–2032
        7.2.1. Y-o-Y Growth Trend Analysis
        7.2.2. Absolute $ Opportunity Analysis
8. Global Gastric Space-Occupying Devices Market Pricing Analysis
    8.1. Regional Pricing Analysis, By Product
    8.2. Global Average Pricing Analysis Benchmark
    8.3. Pricing Assumptions
9. Global Gastric Space-Occupying Devices Market Volume (Units) Analysis 2017–2021 and Forecast, 2022–2032
    9.1. Historical Market Volume (Units) Analysis, 2017–2021, By Product
    9.2. Current and Future Market Volume (Units) Projections, 2022–2032, By Product
        9.2.1. Y-o-Y Growth Trend Analysis
10. Global Gastric Space-Occupying Devices Market Analysis 2017–2021 and Forecast 2022–2032, by Product
    10.1. Introduction / Key Findings
    10.2. Historical Market Size (US$ Mn) Analysis By Product, 2017–2021
    10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Product, 2022–2032
        10.3.1. Gastric Balloons
        10.3.2. Oral Palatal Space Occupying Devices
    10.4. Market Attractiveness Analysis By Product
11. Global Gastric Space-Occupying Devices Market Analysis 2017–2021 and Forecast 2022–2032, by End User
    11.1. Introduction / Key Findings
    11.2. Historical Market Size (US$ Mn) Analysis By End User, 2017–2021
    11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End User, 2022–2032
        11.3.1. Hospitals
        11.3.2. Specialty Clinics
        11.3.3. Ambulatory Surgical Centers
    11.4. Market Attractiveness Analysis By End User
12. Global Gastric Space-Occupying Devices Market Analysis 2017–2021 and Forecast 2022–2032, by Region
    12.1. Introduction
    12.2. Historical Market Size (US$ Mn) Analysis, By Region, 2017–2021
    12.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Region, 2022–2032
        12.3.1. North America
        12.3.2. Latin America
        12.3.3. Europe
        12.3.4. East Asia
        12.3.5. South Asia
        12.3.6. Oceania
        12.3.7. Middle East and Africa (MEA)
    12.4. Market Attractiveness Analysis By Region
13. North America Gastric Space-Occupying Devices Market Analysis 2017–2021 and Forecast 2022–2032
    13.1. Introduction
    13.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2017–2021
    13.3. Current and Future Market Size (US$ Mn) Forecast By Market Taxonomy, 2022–2032
        13.3.1. By Country
            13.3.1.1. U.S.
            13.3.1.2. Canada
        13.3.2. By Product
        13.3.3. By End User
    13.4. Market Attractiveness Analysis
        13.4.1. By Country
        13.4.2. By Product
        13.4.3. By End User
    13.5. Market Trends
    13.6. Key Market Participants - Intensity Mapping
    13.7. Drivers and Restraints - Impact Analysis
    13.8. Country Level Analysis & Forecast
        13.8.1. U.S. Gastric Space-Occupying Devices Market
            13.8.1.1. Introduction
            13.8.1.2. Market Analysis and Forecast by Market Taxonomy
                13.8.1.2.1. By Product
                13.8.1.2.2. By End User
        13.8.2. Canada Gastric Space-Occupying Devices Market
            13.8.2.1. Introduction
            13.8.2.2. Market Analysis and Forecast by Market Taxonomy
                13.8.2.2.1. By Product
                13.8.2.2.2. By End User
14. Latin America Gastric Space-Occupying Devices Market Analysis 2017–2021 and Forecast 2022–2032
    14.1. Introduction
    14.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2017–2021
    14.3. Current and Future Market Size (US$ Mn) Forecast By Market Taxonomy, 2022–2032
        14.3.1. By Country
            14.3.1.1. Brazil
            14.3.1.2. Mexico
            14.3.1.3. Argentina
            14.3.1.4. Rest of Latin America
        14.3.2. By Product
        14.3.3. By End User
    14.4. Market Attractiveness Analysis
        14.4.1. By Country
        14.4.2. By Product
        14.4.3. By End User
    14.5. Market Trends
    14.6. Key Market Participants - Intensity Mapping
    14.7. Drivers and Restraints - Impact Analysis
    14.8. Country Level Analysis & Forecast
        14.8.1. Brazil Gastric Space-Occupying Devices Market
            14.8.1.1. Introduction
            14.8.1.2. Market Analysis and Forecast by Market Taxonomy
                14.8.1.2.1. By Product
                14.8.1.2.2. By End User
        14.8.2. Argentina Gastric Space-Occupying Devices Market
            14.8.2.1. Introduction
            14.8.2.2. Market Analysis and Forecast by Market Taxonomy
                14.8.2.2.1. By Product
                14.8.2.2.2. By End User
        14.8.3. Mexico Gastric Space-Occupying Devices Market
            14.8.3.1. Introduction
            14.8.3.2. Market Analysis and Forecast by Market Taxonomy
                14.8.3.2.1. By Product
                14.8.3.2.2. By End User
15. Europe Gastric Space-Occupying Devices Market Analysis 2017–2021 and Forecast 2022–2032
    15.1. Introduction
    15.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2017–2021
    15.3. Current and Future Market Size (US$ Mn) Forecast By Market Taxonomy, 2022–2032
        15.3.1. By Country
            15.3.1.1. Germany
            15.3.1.2. Italy
            15.3.1.3. France
            15.3.1.4. U.K.
            15.3.1.5. Spain
            15.3.1.6. BENELUX
            15.3.1.7. Russia
            15.3.1.8. Rest of Europe
        15.3.2. By Product
        15.3.3. By End User
    15.4. Market Attractiveness Analysis
        15.4.1. By Country
        15.4.2. By Product
        15.4.3. By End User
    15.5. Market Trends
    15.6. Key Market Participants - Intensity Mapping
    15.7. Drivers and Restraints - Impact Analysis
    15.8. Country Level Analysis & Forecast
        15.8.1. Germany Gastric Space-Occupying Devices Market
            15.8.1.1. Introduction
            15.8.1.2. Market Analysis and Forecast by Market Taxonomy
                15.8.1.2.1. By Product
                15.8.1.2.2. By End User
        15.8.2. France Gastric Space-Occupying Devices Market
            15.8.2.1. Introduction
            15.8.2.2. Market Analysis and Forecast by Market Taxonomy
                15.8.2.2.1. By Product
                15.8.2.2.2. By End User
        15.8.3. Italy Gastric Space-Occupying Devices Market
            15.8.3.1. Introduction
            15.8.3.2. Market Analysis and Forecast by Market Taxonomy
                15.8.3.2.1. By Product
                15.8.3.2.2. By End User
        15.8.4. Spain Gastric Space-Occupying Devices Market
            15.8.4.1. Introduction
            15.8.4.2. Market Analysis and Forecast by Market Taxonomy
                15.8.4.2.1. By Product
                15.8.4.2.2. By End User
        15.8.5. U.K. Gastric Space-Occupying Devices Market
            15.8.5.1. Introduction
            15.8.5.2. Market Analysis and Forecast by Market Taxonomy
                15.8.5.2.1. By Product
                15.8.5.2.2. By End User
        15.8.6. Benelux Union Gastric Space-Occupying Devices Market
            15.8.6.1. Introduction
            15.8.6.2. Market Analysis and Forecast by Market Taxonomy
                15.8.6.2.1. By Product
                15.8.6.2.2. By End User
        15.8.7. Russia Gastric Space-Occupying Devices Market
            15.8.7.1. Introduction
            15.8.7.2. Market Analysis and Forecast by Market Taxonomy
                15.8.7.2.1. By Product
                15.8.7.2.2. By End User
16. South Asia Gastric Space-Occupying Devices Market Analysis 2017–2021 and Forecast 2022–2032
    16.1. Introduction
    16.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2017–2021
    16.3. Current and Future Market Size (US$ Mn) Forecast By Market Taxonomy, 2022–2032
        16.3.1. By Country
            16.3.1.1. India
            16.3.1.2. Thailand
            16.3.1.3. Indonesia
            16.3.1.4. Malaysia
            16.3.1.5. Rest of South Asia
        16.3.2. By Product
        16.3.3. By End User
    16.4. Market Attractiveness Analysis
        16.4.1. By Country
        16.4.2. By Product
        16.4.3. By End User
    16.5. Market Trends
    16.6. Key Market Participants - Intensity Mapping
    16.7. Drivers and Restraints - Impact Analysis
    16.8. Country Level Analysis & Forecast
        16.8.1. India Gastric Space-Occupying Devices Market
            16.8.1.1. Introduction
            16.8.1.2. Market Analysis and Forecast by Market Taxonomy
                16.8.1.2.1. By Product
                16.8.1.2.2. By End User
        16.8.2. Indonesia Gastric Space-Occupying Devices Market
            16.8.2.1. Introduction
            16.8.2.2. Market Analysis and Forecast by Market Taxonomy
                16.8.2.2.1. By Product
                16.8.2.2.2. By End User
        16.8.3. Thailand Gastric Space-Occupying Devices Market
            16.8.3.1. Introduction
            16.8.3.2. Market Analysis and Forecast by Market Taxonomy
                16.8.3.2.1. By Product
                16.8.3.2.2. By End User
        16.8.4. Malaysia Gastric Space-Occupying Devices Market
            16.8.4.1. Introduction
            16.8.4.2. Market Analysis and Forecast by Market Taxonomy
                16.8.4.2.1. By Product
                16.8.4.2.2. By End User
                16.8.4.2.3. By End User
17. East Asia Gastric Space-Occupying Devices Market Analysis 2017–2021 and Forecast 2022–2032
    17.1. Introduction
    17.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2017–2021
    17.3. Current and Future Market Size (US$ Mn) Forecast By Market Taxonomy, 2022–2032
        17.3.1. By Country
            17.3.1.1. China
            17.3.1.2. Japan
            17.3.1.3. South Korea
        17.3.2. By Product
        17.3.3. By End User
    17.4. Market Attractiveness Analysis
        17.4.1. By Country
        17.4.2. By Product
        17.4.3. By End User
    17.5. Market Trends
    17.6. Key Market Participants - Intensity Mapping
    17.7. Drivers and Restraints - Impact Analysis
    17.8. Country Level Analysis & Forecast
        17.8.1. China Gastric Space-Occupying Devices Market
            17.8.1.1. Introduction
            17.8.1.2. Market Analysis and Forecast by Market Taxonomy
                17.8.1.2.1. By Product
                17.8.1.2.2. By End User
        17.8.2. Japan Gastric Space-Occupying Devices Market
            17.8.2.1. Introduction
            17.8.2.2. Market Analysis and Forecast by Market Taxonomy
                17.8.2.2.1. By Product
                17.8.2.2.2. By End User
        17.8.3. South Korea Gastric Space-Occupying Devices Market
            17.8.3.1. Introduction
            17.8.3.2. Market Analysis and Forecast by Market Taxonomy
                17.8.3.2.1. By Product
                17.8.3.2.2. By End User
18. Oceania Gastric Space-Occupying Devices Market Analysis 2017–2021 and Forecast 2022–2032
    18.1. Introduction
    18.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2017–2021
    18.3. Current and Future Market Size (US$ Mn) Forecast By Market Taxonomy, 2022–2032
        18.3.1. By Country
            18.3.1.1. Australia
            18.3.1.2. New Zealand
        18.3.2. By Product
        18.3.3. By End User
    18.4. Market Attractiveness Analysis
        18.4.1. By Country
        18.4.2. By Product
        18.4.3. By End User
    18.5. Market Trends
    18.6. Key Market Participants - Intensity Mapping
    18.7. Drivers and Restraints - Impact Analysis
    18.8. Country Level Analysis & Forecast
        18.8.1. Australia Gastric Space-Occupying Devices Market
            18.8.1.1. Introduction
            18.8.1.2. Market Analysis and Forecast by Market Taxonomy
                18.8.1.2.1. By Product
                18.8.1.2.2. By End User
        18.8.2. New Zealand Gastric Space-Occupying Devices Market
            18.8.2.1. Introduction
            18.8.2.2. Market Analysis and Forecast by Market Taxonomy
                18.8.2.2.1. By Product
                18.8.2.2.2. By End User
19. Middle East and Africa (MEA) Gastric Space-Occupying Devices Market Analysis 2017–2021 and Forecast 2022–2032
    19.1. Introduction
    19.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2017–2021
    19.3. Current and Future Market Size (US$ Mn) Forecast By Market Taxonomy, 2022–2032
        19.3.1. By Country
            19.3.1.1. GCC Countries
            19.3.1.2. Turkey
            19.3.1.3. North Africa
            19.3.1.4. South Africa
            19.3.1.5. Rest of Middle East and Africa
        19.3.2. By Product
        19.3.3. By End User
    19.4. Market Attractiveness Analysis
        19.4.1. By Country
        19.4.2. By Product
        19.4.3. By End User
    19.5. Market Trends
    19.6. Key Market Participants - Intensity Mapping
    19.7. Drivers and Restraints - Impact Analysis
    19.8. Country Level Analysis & Forecast
        19.8.1. GCC Countries Gastric Space-Occupying Devices Market
            19.8.1.1. Introduction
            19.8.1.2. Market Analysis and Forecast by Market Taxonomy
                19.8.1.2.1. By Product
                19.8.1.2.2. By End User
        19.8.2. Turkey Gastric Space-Occupying Devices Market
            19.8.2.1. Introduction
            19.8.2.2. Market Analysis and Forecast by Market Taxonomy
                19.8.2.2.1. By Product
                19.8.2.2.2. By End User
        19.8.3. South Africa Gastric Space-Occupying Devices Market
            19.8.3.1. Introduction
            19.8.3.2. Market Analysis and Forecast by Market Taxonomy
                19.8.3.2.1. By Product
                19.8.3.2.2. By End User
        19.8.4. North Africa Gastric Space-Occupying Devices Market
            19.8.4.1. Introduction
            19.8.4.2. Market Analysis and Forecast by Market Taxonomy
                19.8.4.2.1. By Product
                19.8.4.2.2. By End User
20. Market Structure Analysis
    20.1. Market Analysis by Tier of Companies
    20.2. Market Share Analysis of Top Players
    20.3. Technology Footprint
21. Competition Analysis
    21.1. Competition Dashboard
    21.2. Competition Benchmarking
    21.3. Competition Deep Dive
            21.3.1.1. Apollo Endosurgery, Inc.
                21.3.1.1.1. Overview
                21.3.1.1.2. Product Portfolio
                21.3.1.1.3. Key Financials
                21.3.1.1.4. SWOT Analysis
                21.3.1.1.5. Sales Footprint
                21.3.1.1.6. Key Developments
                21.3.1.1.7. Strategy Overview
            21.3.1.2. Obalon Therapeutics, Inc.
                21.3.1.2.1. Overview
                21.3.1.2.2. Product Portfolio
                21.3.1.2.3. Key Financials
                21.3.1.2.4. SWOT Analysis
                21.3.1.2.5. Sales Footprint
                21.3.1.2.6. Key Developments
                21.3.1.2.7. Strategy Overview
            21.3.1.3. Allurion Technologies, Inc.
                21.3.1.3.1. Overview
                21.3.1.3.2. Product Portfolio
                21.3.1.3.3. Key Financials
                21.3.1.3.4. SWOT Analysis
                21.3.1.3.5. Sales Footprint
                21.3.1.3.6. Key Developments
                21.3.1.3.7. Strategy Overview
            21.3.1.4. Helioscopie
                21.3.1.4.1. Overview
                21.3.1.4.2. Product Portfolio
                21.3.1.4.3. Key Financials
                21.3.1.4.4. SWOT Analysis
                21.3.1.4.5. Sales Footprint
                21.3.1.4.6. Key Developments
                21.3.1.4.7. Strategy Overview
            21.3.1.5. Endalis
                21.3.1.5.1. Overview
                21.3.1.5.2. Product Portfolio
                21.3.1.5.3. Key Financials
                21.3.1.5.4. SWOT Analysis
                21.3.1.5.5. Sales Footprint
                21.3.1.5.6. Key Developments
                21.3.1.5.7. Strategy Overview
            21.3.1.6. MEDSIL
                21.3.1.6.1. Overview
                21.3.1.6.2. Product Portfolio
                21.3.1.6.3. Key Financials
                21.3.1.6.4. SWOT Analysis
                21.3.1.6.5. Sales Footprint
                21.3.1.6.6. Key Developments
                21.3.1.6.7. Strategy Overview
            21.3.1.7. ReShape Medical, Inc.
                21.3.1.7.1. Overview
                21.3.1.7.2. Product Portfolio
                21.3.1.7.3. Key Financials
                21.3.1.7.4. SWOT Analysis
                21.3.1.7.5. Sales Footprint
                21.3.1.7.6. Key Developments
                21.3.1.7.7. Strategy Overview
            21.3.1.8. Lexel Medical
                21.3.1.8.1. Overview
                21.3.1.8.2. Product Portfolio
                21.3.1.8.3. Key Financials
                21.3.1.8.4. SWOT Analysis
                21.3.1.8.5. Sales Footprint
                21.3.1.8.6. Key Developments
                21.3.1.8.7. Strategy Overview
            21.3.1.9. Scientific Intake
                21.3.1.9.1. Overview
                21.3.1.9.2. Product Portfolio
                21.3.1.9.3. Key Financials
                21.3.1.9.4. SWOT Analysis
                21.3.1.9.5. Sales Footprint
                21.3.1.9.6. Key Developments
                21.3.1.9.7. Strategy Overview
22. Assumptions and Acronyms Used
23. Research Methodology
Recommendations

Healthcare

Gastric Bands Market

September 2024

REP-GB-14102

250 pages

Healthcare

Gastric Electrical Stimulators Market

August 2023

REP-GB-4044

303 pages

Explore Healthcare Insights

View Reports
Future Market Insights

Gastric Space-Occupying Devices Market

Schedule a Call